Skip to main content

Advertisement

Log in

Role of second trimester maternal serum markers as predictor of preeclampsia

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the variations and potential clinical use of second trimester serum markers as predictor of preeclampsia.

Methods

In a prospective study β HCG, α feto protein and inhibin A levels were estimated in 50 antenatal women in the second trimester (12–24 weeks) by ELISA technique. Results were noted in terms of development of preeclampsia, mean serum levels of all three markers, mode of delivery and fetal outcome.

Resuflts

Out of 50 women, 10 developed preeclampsia (20%). A significant rise of mean serum β HCG level (16130.2 MIU/ml, >2.5 MoM,p <0.001), mean serum AFP level (161.7 ng/ml, >2.5 MoM, P<0.001) and mean inhibin-A level (1248.49 pg/ml, >2.0 MoM, P<0.001) was present in those who developed preeclampsia. Out of 10 preeclamptic women one had IUD, four fetuses were growth retarded, two babies were born before term and six were low birth weight babies, whereas out of 40 normotensive women only five had IUGR, three preterm delivery and 32 delivered at term without and complication.

Conclusions

A significant positive correlation between second trimester serum markers and development of preeclampsia was observed (p<0.001). Thus with the second trimester serum marker study, prediction of preeclampsia is possible at incipient stage and its adverse pregnancy outcome can be minimized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gravett CP, Buckmaster JG, Watson PT et al. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet 1992;44:485–486.

    Article  PubMed  CAS  Google Scholar 

  2. Gonen R, Perez R, David M et al. The association between unexplained second trimester maternal serum HCG elevation and pregnancy complication. Obstet Gynecol 1992;80:83–86.

    PubMed  CAS  Google Scholar 

  3. Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict preeclampsia. Br J Obstet Gynaecol 1998;105:1101–1103.

    Article  PubMed  CAS  Google Scholar 

  4. Yaron Y, Cherry M, Kramer RL et al. Second-trimester maternal serum marker screening: maternal serum alphafetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999;181:968–974.

    Article  PubMed  CAS  Google Scholar 

  5. Aquilina J, Maplethorpe R, Ellis P et al. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia. Placenta 2000;21:487–492.

    Article  PubMed  CAS  Google Scholar 

  6. Duric K, Skrablin S, Lesin J et al. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol 2003;110:12–15.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dayal, M., Gupta, P., Varma, M. et al. Role of second trimester maternal serum markers as predictor of preeclampsia. J Obstet Gynecol India 61, 38–41 (2011). https://doi.org/10.1007/s13224-011-0014-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-011-0014-y

Keywords

Navigation